Siemens and LabCorp Enter Agreement to Co-Develop Clinical Diagnostic Tests
News May 09, 2008
Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. Under the agreement, initial discussions will focus on developing new tests that could make the biggest impact to patient care.
Companion diagnostics are tests designed to identify the suitability between patients and a particular drug therapy. The tests can be used in personalized medicine to improve safety and efficacy of therapeutic drugs and in some cases, may help determine optimal dosing for individual patients.
"This agreement establishes a framework that gives both companies the opportunity to offer new diagnostic tests to laboratories, physicians and their patients more quickly and effectively than either could do alone," said Dave Hickey, senior vice president strategic planning and business development, Siemens Healthcare Diagnostics.
"Advancing health care for patients is an important commitment that we can reach through strategic relationships such as this."
Mouse Study Suggests That Dietary Fat, Not Carbs, Drives ObesityNews
A mouse study that made over 100,000 measurements of body weight and fat has concluded that the sole driver of obesity in mice is increased dietary fat content.READ MORE
Peering Inside ProteinsNews
The proteins in our bodies are sophisticated structures that perform specific jobs to keep us functioning and healthy. Understanding how a protein is wired could help researchers develop ways to control its activity. A new technique lets researchers look into the atomic structures of proteins to see that wiring.READ MORE
This ATM Dispenses AntioxidantsNews
Antioxidants are molecules that counteract the damage to our bodies from harmful products of normal cells called reactive oxygen species (ROS). Now, research has found that a protein called ATM can sense the presence of ROS and responds by sounding the alarm to trigger the production of antioxidants.READ MORE